Doctor profile · Federal record
Dr. Mark Charbonnet, MD
Hematology & Oncology Physician (CMS: General Practice) · New Iberia, LA
- NPI 1891718177
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 30 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
602 N Lewis St, Suite 600
New Iberia, LA 705632093
(337) 560-5510
fax (337) 560-5554 - Mailing address
-
Po Box 12109
New Iberia, LA 705622109
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- January 21, 2022
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Louisiana #023042
- Medicaid
- LA #1490601
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1891718177. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
50,161
Distinct HCPCS
10
Medicare allowed
$760,011
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3111 |
Injection, romosozumab-aqqg, 1 mg | 15,960 | 13 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 15,780 | 152 | $23 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 3,906 | 11 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,582 | 11 | $0 | |
96372 |
Injection of drug or substance under skin or into muscle | 1,829 | 266 | $13 | |
96375 |
Injection of additional new drug or substance into vein | 1,082 | 31 | $14 | |
J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 1,068 | 267 | $2 | |
J1644 |
Injection, heparin sodium, per 1000 units | 786 | 25 | $0 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 681 | 116 | $84 | |
J7050 |
Infusion, normal saline solution, 250 cc | 678 | 40 | $1 |
In context: peer comparison
Among 1 peers in New Iberia Hematology & Oncology Physician, average services per provider: 1,857. This provider delivers 27× the peer median.Open Payments
Industry payments received
All-time total
$2,858
Transactions
27
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 5 | $2,013.68 | |
| Janssen Biotech, INC. | 4 | $171.88 | |
| Astellas Pharma US INC | 1 | $124.62 | |
| Merck Sharp & Dohme LLC | 1 | $89.92 | |
| SpringWorks Therapeutics, INC. | 1 | $67.41 | |
| Bayer Healthcare Pharmaceuticals INC. | 2 | $59.27 | |
| Gilead Sciences, INC. | 1 | $55.76 | |
| Novartis Pharmaceuticals Corporation | 3 | $55.58 | |
| Pfizer INC. | 3 | $48.79 | |
| Mirati Therapeutics, INC. | 1 | $21.91 | |
| BeiGene USA, INC. | 1 | $20.26 | |
| Lilly USA, LLC | 1 | $19.14 | |
| Ipsen Biopharmaceuticals, INC | 1 | $17.51 | |
| Pharmacosmos Therapeutics INC. | 1 | $17.19 | |
| Puma Biotechnology, INC. | 1 | $16.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
207
Patients
0
Total drug cost
$368,626
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 62 | 0 | $1,051 |
| Hydroxyurea | Generic | 54 | 0 | $1,143 |
| Eliquis (Apixaban) | Brand | 15 | 0 | $9,069 |
| Xarelto (Rivaroxaban) | Brand | 15 | 0 | $12,866 |
| Anastrozole | Generic | 13 | 0 | $340 |
| Lenalidomide | Generic | 13 | 0 | $140,136 |
| Exemestane | Generic | 12 | 0 | $400 |
| Ibrance (Palbociclib) | Brand | 12 | 0 | $203,551 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 11 | 0 | $70 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Charbonnet's medical specialty?
Dr. Mark Charbonnet practices Hematology & Oncology Physician in New Iberia, LA.
Where does Dr. Mark Charbonnet practice?
Dr. Mark Charbonnet practices at 602 N Lewis St, New Iberia, LA 705632093. Office phone: 3375605510.
What is Dr. Mark Charbonnet's NPI?
Dr. Mark Charbonnet's National Provider Identifier (NPI) is 1891718177, issued by NPPES.
Does Dr. Mark Charbonnet accept Medicare assignment?
Yes. Dr. Mark Charbonnet accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Charbonnet commonly perform?
Top Medicare-reported procedures in 2023: Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897); Injection, ondansetron hydrochloride, per 1 mg (HCPCS J2405). Source: CMS Medicare Physician & Other Practitioners file.